Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy

NCT04394247 · clinicaltrials.gov ↗
COMPLETED
Status
242
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer